Search for European Projects

26 European Projects Found

Searched on 125080 European Projects

 ONGOING 

European Human Biomonitoring Initiative (HBM4EU)

Start date: Jan 1, 2017, End date: Dec 31, 2021,

The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemicals and so protect human health. We will use human biomonitoring to understand human exposure to chemicals and resulting health impacts and will communicate with policy makers to ensure that our results are exploited in the design of new chemicals policies an ...
Read Project

 43

 ONGOING 

ERA-NET ON NANOMEDICINE (EuroNanoMed III)

Start date: Nov 1, 2016, End date: Oct 31, 2021,

Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for a better understanding of the biological mechanisms of diseases at the molecular level, leading to new targets for earlier and more precise diagnostics and therapeutics. Nanomedicine, rated amo ...
Read Project

 25

 ONGOING 

European Research Area on Sustainable Animal Production Systems (SusAn)

Start date: Mar 1, 2016, End date: Feb 28, 2021,

This proposal seeks funding under the Horizon 2020 Work Programme 2014-2015 to establish an ERA-NET for joint European research coordination on Sustainable Animal Production (SusAn). The scope for this ERA-NET has been developed under the SCAR Collaborative Working Group on Sustainable Animal Production (CWG-SAP). Funding organisations from 22 European countries initially seek to support one co-fu ...
Read Project

 37

 ONGOING 
The ERA-NET NEURON Cofund will coordinate and align European and international research funding programmes in the area of brain-related diseases and disorders of the nervous system. Key activity is the implementation of an EC co-funded joint transnational call for research proposals. The mission of NEURON is based on the fact that disorders of the brain are the major cause for impaired quality of ...
Read Project

 22

 ONGOING 
The potential of Personalised Medicine (PM) is to improve prevention, diagnosis and treatment of diseases by taking into account individuals' genotypes and phenotypes as well as other biomedical, life style and environmental data. In the last decade, significant advancements have been made especially for cancer or rare diseases. However, due to fragmentation and high upfront-investments the implem ...
Read Project

 4

 ONGOING 
Antibiotic resistance is a global problem. It is considered by the World Health Organization as one of the three greatest threats to human health for the next decades. ’Enhanced coordination across national boundaries is needed to accelerate the efforts to tackle this grand challenge. Such synergies have been created among 19 countries in Europe and beyond through the EU JPI on Antimicrobial Resis ...
Read Project

 19

 ONGOING 
Cardiovascular diseases (CVD) are the largest cause of death in the EU and account for around 2 million deaths per year. Overall, CVD are estimated to cause the economy of the EU costs of almost 196 billion Euros a year. Furthermore, they are one of the leading causes of long term sickness, chronic diseases and loss to the labour market. Therefore, CVD are a major health problem in Europe. Despite ...
Read Project

 23

 ONGOING 
Cancer is a worldwide health burden and represents a major public health challenge in Europe. It is responsible for 25% of all deaths, being the second most common cause of death after cardio-vascular diseases and the main cause of mortality among people aged 45–64. Today, an estimated 9 million individuals in Europe live with cancer (Globocan 2008, http://globocan.iarc.fr/). Cancer became a chron ...
Read Project

 30

 ONGOING 
Over 12 million people in Europe suffer from neurodegenerative diseases (ND), yet treatments that prevent or stop the progression of neurodegeneration are still lacking. Tackling this grand challenge requires enhanced coordination of national efforts to accelerate discovery. Such synergies have been created among 28 countries in the pilot EU JPI on Neurodegenerative Disease Research (JPND). JPND h ...
Read Project

 26

 ONGOING 
Systems medicine is a new approach which integrates biological and medical data with mathematical and computational modelling in order to understand the underlying mechanisms of disease and to develop new strategies for individualised diagnosis, treatment and prevention. Systems medicine can fill the gap between experimental data produced by modern technologies and medical knowledge. Through the i ...
Read Project

 15

 ONGOING 
In order to strengthen the sustainability and resilience of health services and systems a unique consortium of governmental and funding organizations plus research institutes, has expressed the ambition to systematically learn from the organisation of care in other settings. Overall objective of TO-REACH is to provide groundwork for an ERA-NET that will contribute to the resilience, effectiveness, ...
Read Project

 31

 ONGOING 

ERA-NET rare disease research implementing IRDiRC objectives (E-Rare-3)

Start date: Dec 1, 2014, End date: Nov 30, 2019,

Rare diseases (RD) are diseases that affect not more than 5 per 10 000 persons (according to the EU definition). 7000 distinct rare diseases exist, affecting between 6% and 8% of the population (about 30 million EU citizens). The lack of specific health policies for rare diseases and the scarcity of the expertise, translate into delayed diagnosis, few medicinal products and difficult access to car ...
Read Project

 27

 ONGOING 

Common Agriculutral and wider bioeconomy reSearch Agenda (CASA)

Start date: Sep 1, 2016, End date: Aug 31, 2019,

The overall objective of CASA is a consolidated common agricultural and wider bioeconomy research agenda within the European Research Area. The common research agenda will be jointly shared by Member States of the European Union and Associated Countries. It will improve the alignment and interoperability of the respective national research programme(s). This will be achieved through enhanced coope ...
Read Project

 10

 FINISHED 
Nanomedicine, the application of nanotechnology to health, is a fast-growing field with a large potential for improving diagnostics and therapeutic solutions in many diseases. The EuroNanoMed II (ENM II) consortium, with 20 partners from 17 countries and regions, aims to foster the competitiveness of European nanomedicine actors through the support of translational research projects enhancing tran ...
Read Project

 25

 FINISHED 
The CREDITS4HEALTH project’s main goal is to develop a person centric approach based on the “credits for health” concept to reduce sedentary behavior and enhance the level of physical activity and healthy dietary styles in people living in Euro-Mediterranean Countries. The concept of credits is simple and effective: this means that each participant will earn credits from his local, regional or nat ...
Read Project

 16

 FINISHED 
Research into the human brain and its diseases is one of the key challenges of our century, since among the many diseases affecting health, disorders of the brain are major causes for impaired quality of life. Despite some progress in understanding the molecular mechanisms of the various neurological and psychiatric disorders, research is far from being able to offer solutions how to conquer them ...
Read Project

 24

 FINISHED 

Animal Health and Welfare (ANIHWA)

Start date: Jan 1, 2012, End date: Dec 31, 2015,

The activities of consumer groups and animal protectionists and the effects of large-scale sanitary crises have increased the awareness that animal production is more than just an industry. Farm animal welfare is now clearly an important issue for people across Europe and there is clear demand for higher animal welfare standards. Exotic or emerging infectious threats are ever present and their pot ...
Read Project

 33

 FINISHED 
The Health Directorate of the European Commission's DG Research and Innovation recently stated that Personalized Medicine is one of the most innovative areas in the future of health research with a high potential for patients, citizens and the economy. However, today the full potential can not be developed due to fragmented activities, insufficient communication and lack of generic solutions in th ...
Read Project

 18

 FINISHED 
J-AGE, the Coordination Action for the early implementation of the Joint Programming Initiative (JPI) 'More Years – Better Lives – the Challenges and Opportunities of Demographic Change', will support and foster the overall management of the JPI, the development of the Strategic Research Agenda and its implementation through joint activities between Member States, the mapping of relevant national ...
Read Project

 11

 FINISHED 
Animal diseases can cause serious social, economic and environmental damage and in some cases also threaten human health. An increasing number of the major disease problems or threats faced by the livestock industry and zoonoses are of a global nature. The overall aim of the global strategic alliances for the coordination of research on the major infectious diseases of animals is to improve coordi ...
Read Project

 22

 FINISHED 

ERA-NET on Translational Cancer Research (TRANSCAN)

Start date: Jan 1, 2011, End date: Dec 31, 2014,

"Cancer is a worldwide health burden and a major public health challenge in Europe, responsible for 25% of all deaths; a situation expected to worsen with population ageing. The strengthening of translational cancer research is an urgent need in European cancer research, i.e. the integration of basic, epidemiological, preclinical and clinical research with the implementation and evaluation of inte ...
Read Project

 29

 FINISHED 
Initiated by the EU Member States and supported by the European Commission the EU eHealth Governance Initiative was set up in 2009. This political initiative will be supported by two different instruments: the proposed Joint Action – eHealth Governance Initiative and the Thematic Network SEHGovIA. Defined areas of work of the eHealth Governance Initiative are legal issues, semantics and technical ...
Read Project

 36

 FINISHED 
Medically related Life Sciences use the mouse as a model system to understand the molecular basis of health and disease in humans (>95% similarity of genes in humans and mice). An essential task for Biomedical Sciences in the 21st century will be the functional analysis of mouse models for every gene in the mammalian genome. The major bottlenecks identified by the user community will be proper ...
Read Project

 29

 FINISHED 
"The disease threats to the livestock industry have increased steadily over the past decades as a result of globalisation, evolving pathogens and climate change. Responding to animal disease threats relies heavily on science; research makes a significant contribution to the development of disease control policy and the translation of policy, and other drivers for improving animal health, into prac ...
Read Project

 29

 FINISHED 
Efficient translation of research discoveries into industrial application is an essential element to maintain Europe’s competitiveness in the biomedical and health industry. The main bottleneck is the lack and the fragmented nature of essential research infrastructure and know-how, leading to unacceptable delays and/or preventing the development of new innovative medicines. The aim of EATRIS is to ...
Read Project

 20

 FINISHED 
A shot in the arm for the health sector : The METE project aims to analyse and evaluate medical and paramedical training within the EU. The project intends to then propose a methodology for continuous training for adoption by the partner countries, aiming to ensure an equally high level of treatment for all patients. This project started in 2002 and lasted 36 months.
Read Project

 12